Literature DB >> 6711745

Absence of dengue 2 infection enhancement in human sera containing Japanese encephalitis antibodies.

R Putvatana, S Yoksan, T Chayayodhin, N Bhamarapravati, S B Halstead.   

Abstract

Sera from 52 young adults resident in a rural area in North Thailand were studied for plaque-reducing neutralizing antibodies against dengue (DEN) viruses types 1-4 and Japanese encephalitis (JE), and for DEN-2 infection-enhancing antibodies using a newly described microtest in the human monocyte cell line, U-937. Infection-enhancing antibody titers in U-937 cells using a simplified micromethod were similar to results obtained by published methods using human peripheral blood leukocytes and a macrotest using U-937 cells. In the sample, there were 23 with antibodies to one or more DEN viruses with or without accompanying JE antibodies; 16 sera demonstrated antibodies only to JE and 13 had no detectable antibodies to any flavivirus. All but two DEN antibody-containing sera enhanced DEN-2 infections in U-937 cells, often to titers of 1:10,000 or greater. By contrast, only one of 16 JE-immune sera enhanced DEN-2 infection in monocytes, and that at a dilution of 1:100. None of the flavivirus-negative sera had DEN-2 enhancing activity. The failure of human anti-JE contrasts with the ability of rabbit anti-JE to enhance DEN-2 infections, but correlates with the absence of recorded instances of dengue shock syndrome in human beings sequentially infected with JE and then a DEN virus. This report seemingly reconciles in vitro and in vivo phenomena, and may provide an opportunity to study mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6711745     DOI: 10.4269/ajtmh.1984.33.288

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

Review 1.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

2.  Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers.

Authors:  N Bhamarapravati; S Yoksan; T Chayaniyayothin; S Angsubphakorn; A Bunyaratvej
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 3.  Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.

Authors:  Scott B Halstead; Suresh Mahalingam; Mary A Marovich; Sukathida Ubol; David M Mosser
Journal:  Lancet Infect Dis       Date:  2010-10       Impact factor: 25.071

4.  Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand.

Authors:  Kathryn B Anderson; Robert V Gibbons; Stephen J Thomas; Alan L Rothman; Ananda Nisalak; Ruth L Berkelman; Daniel H Libraty; Timothy P Endy
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.